Related Experiment Video
Updated: Feb 24, 2026
Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
Published on: January 16, 2015
[Systemic inflammatory profile of smokers with and without COPD]
Y Mosrane1, M Bougrida2, A S Alloui3
1Laboratoire de biologie cellulaire et moléculaire, faculté des sciences de la vie et de la nature, université Constantine 1, Constantine, Algérie.
Smokers with Chronic Obstructive Pulmonary Disease (COPD) exhibit significantly higher systemic inflammation markers, including C-reactive protein and interleukins, compared to smokers without COPD. This study highlights a distinct inflammatory profile in COPD patients who smoke.
Area of Science:
- Pulmonary Medicine
- Immunology
- Biomarker Research
Background:
- Systemic inflammatory profiles in smokers with and without COPD have yielded inconsistent findings in previous research.
- Understanding these differences is crucial for targeted therapeutic strategies.
Purpose of the Study:
- To comparatively analyze the systemic inflammatory profile between active smokers diagnosed with COPD and those without the condition.
Main Methods:
- A cross-sectional study involving 56 stable COPD patients and 32 non-COPD smokers (all with >10 pack-years smoking history).
- Blood biomarkers including leukocytes, hemoglobin, TNF-α, IL-6, CRP, and ESR were measured.
- Participants were categorized based on normal/abnormal biomarker levels.
Main Results:
- The COPD group was older and had a higher smoking consumption than the non-COPD group.
- Elevated levels of CRP, ESR, IL-6, and TNF-α were significantly higher in smokers with COPD.
- A greater percentage of COPD smokers displayed elevated CRP, leukocytosis, and higher IL-6/TNF-α levels.
Conclusions:
- Smokers with COPD demonstrate a pronounced systemic inflammatory response compared to smokers without COPD.
- This heightened inflammation is a key characteristic differentiating these two groups of smokers.
More Related Videos
06:07Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
Published on: October 22, 2020
09:07Author Spotlight: Development and Characterization of an In Vitro Model to Study Chronic Cigarette Smoke Exposure and Its Impact on Airway Epithelial Cells in COPD Research
Published on: July 12, 2024
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: